Mycronic AB (publ), interim report January-September 2016

New Post Public Reply Private Reply Replies (0) Message Board

News Desk 2018

Oct 20, 2016 at 2:15 AM

Nine months of strong order intake - execution of strategy for growth Mycronic demonstrated a strong financial performance during the first nine months of the year. Order intake and net sales increased 44 and 9 percent respectively. The operating margin reached 22 percent. Demand for the Group’s products is favorable, thanks to product launches which broadened the Group’s addressable market. Mycronic also has major focus on investments for future growth, both through initiatives in product development and through acquisitions. Third quarter July-September 2016 · Order intake was SEK 367 (559) million · Net sales were SEK 497 (605) million · EBIT was SEK 148 (262) million · Earnings per share was SEK 1.17 (2.33) Period January-September 2016 · Order intake reached SEK 1,936 (1,341) million · Net sales reached SEK 1,303 (1,194) million · EBIT was SEK 286 (289) million · Earnings per share was SEK 2.25 (2.52) Outlook The Board’s assessment remains, that net sales in 2016 will be at the level of SEK 1,900 million, excluding effects from acquisitions. CEO comments The first nine months demonstrated good demand for Mycronic’s production solutions. Order intake increased 44 percent compared with the same period 2015 and net sales increased 9 percent. We are making significant investments in product development to maintain our competitive edge. And we report an EBIT of SEK 286 million, or a margin of 22 percent, for the first nine months. The order backlog reached SEK 1,699 million. The global market for SMT equipment experienced a negative trend in 2015, while Mycronic maintained volumes and margins. In 2016, the slowdown has affected business area SMT, primarily during the first half year. The trend in the third quarter was positive with an increase in the order intake and net sales com -pared with the third quarter 2015. Mycronic has received orders for nine mask writers thus far in 2016. The newly launched the Prexision-800, which ensures effective production of the most complex photomasks for the smart 4K phones and advanced AMOLED displays of the future. The replacement offering provides customers with a solution to secure long-term high productivity in photomask manufacturing. Investments in product development within SMT equipment continue, in line with the strategy. We have launched new products and in this way broadened our product offering, which creates opportunities for growth. The introduction of an updated MY600 for dispensing of several different mounting fluids targets new segments on the SMT market, both from geographic and product perspectives. The introduction has been well received on the market. To achieve long-term, sustainable growth Mycronic’s strategy includes M&As. During 2016, we acquired the German company RoyoTech, which developed the strategic storage solutions that are an integrated part of Mycronic’s offering for the smart factory. In August, an agreement was signed on the acquisition of Axxon, a leading actor on the dispensing market in China. The acquisition is strategically important as Axxon’s technology and market position complement our own position, which make us a leading global actor. Mycronic is continuing to execute the growth strategy at a high pace, while at the same time delivering good results. Lena Olving, CEO and President Contacts at Mycronic: Lena Olving CEO and President +46 8 - 638 52 00 lena.olving@mycronic.com Per Ekstedt CFO +46 8 - 638 52 00 per.ekstedt@mycronic.com About Mycronic Mycronic AB is a high-tech Swedish company engaged in developing, manufacturing and marketing of production solutions to the electronics industry. Mycronic headquarters are located in Täby, north of Stockholm and the Group has subsidiaries in China, France, Germany, Japan, Singapore, South Korea, Taiwan, the Netherlands, United Kingdom and the US. For more information, see the company website www.mycronic.com. Mycronic AB (publ) is listed on NASDAQ Stockholm, Mid Cap: MYCR. This interim report is a translation of the Swedish version. In the event of any differences between this translation and the Swedish original version, the Swedish version shall have precedence.

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Warehouse Strike Over Pensions Jolts AGNE Operations

AGNE Feels Heat as Teamsters Strike Over Pensions Damn near thought we'd seen it all, but here we are, bearings rattled by yet another strike at a time when disruption seems to be the tune of the day. Over 255 members of Teamsters Local 633 have locked horns with Associated Grocers Northeast (AGNE) in Pembroke, New Hampshire. It's not about nickel-and-diming over a pay...

AI in Healthcare: Real Results Unveiled at HLTH 2026

Transforming Healthcare with AI The landscape of healthcare is constantly evolving, and this time, we're diving deep into how AI is shaking things up. MCG Health and Telligen, both heavyweights in the health sector, are stepping into the limelight at the HLTH 2026 conference. This ain't just any run-of-the-mill presentation; it's where the rubber meets the road in...

Marini SkinSolutions Wins with Night Zyme Complex

Shaking Up the Skincare Scene You don't often see a skincare product snag three prestigious awards in one year, but that's exactly what's unfolding for Marini SkinSolutions. This time, their Night Zyme® Overnight Glass Skin Resurfacing Complex grabbed the 2026 Shop TODAY Ageless Beauty Award. It’s turning heads and not just in beauty aisles but among investors eyeing a...

GAC Hits Record with 223,000 Units Exported in 2026

GAC Gaining Ground Globally in 2026 China's GAC is making waves with its recent export figures. They've blitzed past the competition, exporting 223,000 units from January to October 2026. That's not just a number, it’s a record, with October alone seeing a hefty 26,017 units shipped—marking an impressive 80.8% growth compared to last year. A Strategic Push in Europe...

Mondego Bio Charges Ahead with Cancer Therapy Trials

Cracking Cancer's Code: Mondego's Bold Move Big news from Portugal today—a quiet town called Cantanhede is now the epicenter of a potential game-changer in cancer therapy. Mondego Bio, with its small-molecule innovator MB?388, is diving headfirst into a Phase 1 clinical study. If you're scratching your head about the significance, let me spell it out: this is an attempt...

Bram Schot Steers Marelli Through Chapter 11 Resurgence

So, Marelli's rolling out the heavy artillery with the appointment of Bram Schot as their future Chair. This isn't just reshuffling a few chairs on the deck of a wobbly ship. No, Marelli's emergence from Chapter 11, with Schot at the helm, is more akin to a full-blown course correction. The man comes seasoned, having braved the corporate gales at Audi, Mercedes-Benz, and...

Attilio's Longevity Push: Science with a Personal Touch

Reimagining Longevity: Beyond Just Adding Years Guess what? Living longer isn't just about reaching the milestone of blowing out 100 birthday candles. That's the message Attilio drilled home during their recent Longevity Event. And let me tell you, it was quite a doozy—from what went down at Stanford to a deep dive at the Buck Institute, it was an eye-opening affair....

SKF's Industrial Push: Energy Efficiency at COP31

SKF's Green Initiative: A Major Step Forward You ever find yourself in a room full of big players, each trying to outdo the other? That's the stage set for SKF at COP31, where they're not just strutting around showing off but actually offering some substance—a rarity in these highbrow gatherings. They're juicing up the talk around energy efficiency and circularity...

Dill Dinkers Eyes Next Growth Phase with Local Deal

A Leap Toward Future Growth You know, not every day does a company manage to turn its early beginnings into a robust franchise system, but Dill Dinkers seems to be onto something here. This pickleball outfit is tossing its original Maryland clubs to local hands, and it’s not just a transaction—it’s a calculated play intending to solidify their expansion path...

FirstService Jolts Mira Mar Redesign Masterplan

Sarasota's Mira Mar Finds Its Match Holy smokes! Sarasota's making waves again as Mira Mar, the high-end luxury condominium development, ropes in FirstService Residential to give it that extra oomph. Now, we're talkin’ about a real shake-up in downtown Sarasota real estate. The game here isn’t just grabbing a slice of the pie; it's the whole damn pie. Luxury Living...